Competitive Abstract Submission

International

New York, USA, November 2014, Veith Symposium: 41st Annual Symposium on Vascular and Endovascular Issue

1. Illness Severity Scoring Systems and Risk Prediction in Vascular Intensive Care Admissions
2. Treatment of Thoracoabdominal Aortic Aneurysms and Dissections with the Multilayer Flow Modulator: A Systematic Review
3. Contemporary Management of Critical Lower Limb Ischaemia in TASC D lesions with Subintimal Angioplasty in femoro-popliteal lesions , Tibial Angioplasty and Sequential compression biomechanical device for Infra-inguinal Arterial Occlusion. Experience and Quality of life outcome learned over 25 years.

Liege, Belgium, September 2014, IMAD 2014: 4^th International Meeting on Aortic Diseases

1. Lessons Learned from Using the Multilayer fluid Modulator Outside of Indications for Use in 38 Cases.
2. Evaluation of the multilayer flow modulator in aneurysm repair using porcine animal models.
3. Changes in thread design of the multilayer flow modulator and the effects on biocompatibility.

7. Endothelization kinetics of multilayer versus single layer intra-arterial stents.

Guangzhou, China, July 2014, International Society of Vascular Surgery, Annual Congress

1. Illness Severity Scoring Systems and Risk Prediction in Vascular Intensive Care Admissions
2. Endothelialisation processes and kinetics of stents.

Nice, France, April 2014 , Congress of the ESCVS (European Society for Cardiovascular & Endovascular Surgery) 2014

1. Illness severity scoring systems and risk prediction in vascular intensive care admissions: which score is best for contemporary practice?
2. Early mid-term results of the first 103 cases of multilayer flow modulator stent done under indication for use in the management of thoraco-abdominal aortic pathology from the independent global MFM registry

London UK, April 2014 , Charing Cross international symposium 2014

1. Illness severity scoring systems and risk prediction in vascular intensive care admissions: which score is best for contemporary practice?
2. Early mid-term results of the first 103 cases of multilayer flow modulator stent done under indication for use in the management of thoraco-abdominal aortic pathology from the independent global MFM registry
3. When Not to Implant the Multilayer Flow Modulator: Lessons Learned From Application Outside the Indications in Patients With Thoracoabdominal Pathologies

Barcelona, Spain, September 2013, CIRSE 2013, Cardiovascular and Interventional Radiology Society of Europe.

1. One-Year Results of the Multilayer Flow Modulator Stent in the Management of Thoracoabdominal Aortic Aneurysms.

San Francisco, USA, May 2013, Society for Vascular Surgery Annual Meeting.

1. One-Year Results of the Multilayer Flow Modulator Stent in the Management of Thoracoabdominal Aortic Aneurysms.

Miami, Florida, USA, March 2013, Society for Clinical Vascular Surgery 40th Annual Symposium.

1. The Effects of Normalising Hyperhomocysteinemia on Clinical and Operative Outcomes in Patients with Critical Limb Ischaemia

Chicago, Illinois, USA, October 2012, American College of Surgeons Annual Clinical Congress

1. Disruptive Endovascular Technology with Multilayer Flow Modulator Stents (MFM) as a Therapeutic Option in the Management of Thoraco-abdominal Aortic Aneurysms. Early Results form the Global Independent MFM Registry

London, UK, October 2012, The London Cardiovascular Symposium 2012, the Royal Society of Medicine

1. Spontaneous Aortic rupture due to Human Immunodeficiency Virus Associated Vasculitis: A Case I wish Ii Hadn’t done
2. Endovascular Management of Multiple Aneurysms secondary to Hyper-eosinophilia Syndrome
3. Subacute anterior spinal cord ischaemia with lower limb paraplegia in a patient with thoracoabdominal aortic aneurysm

Washington D.C., USA, June 2012, Society for Vascular Surgery Annual Meeting.

1. Multilayer Flow Modulator Stents (MFM) as a Therapeutic Option in the Management of Thoracoabdominal Aortic Aneurysms

Houston, Texas, USA, April 2012, The Houston Aortic Summit

1. Paradigm Shift in Ruptured AAA (RAAA) Management: Twelve Years Experience in a Tertiary Referral Centre of Endovascular Repair of RAAA(REVAR) Vs. Open Repair (OR)

24. Cool Excimer Laser Assisited Angioplasty (CELA) VS Tibial Balloon Angioplasty (TBA) in Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI) TASC DE. A Pivotal Observational Analogy Congregate Proportional Analysis over 48 months. “Six L Trial”

San Francisco, California, USA, October 2011, American College of Surgeons 97th Annual Clinical Congress

1. Paradigm Shift in Ruptured AAA (RAAA) Management: Twelve Years Experience in a Tertiary Referral Centre of Endovascular Repair of RAAA(REVAR) Vs. Open Repair (OR)
2. A Mid to Long-term Experience of Clinical Efficacy and Cost per Quality-Adjusted Life Years with Pararenal Endovascular Aortic Repair (PEVAR) without Fenestration for Para-renal AAA compared with Open Surgical Repair

Athens, Greece, September 2011, ESVS, European Society of Vascular Surgery Annual Meeting

1. Disruptive Endovascular Technology with Multilayer Stents as a Therapeutic Option in the Management of a Thoracoabdominal Aortic Aneurysm.

Munich, Germany, September 2011, CIRSE 2011, Cardiovascular and Interventional Radiology Society of Europe.

1. A mid- to long-term experience of clinical efficacy and cost per quality-adjusted life years with pararenal endovascular aortic repair (PEVAR) without fenestration for pararenal AAA compared with open surgical repair
2. Five-year Irish trial of CLI patients with TASC II type C/D lesions undergoing subintimal angioplasty (SIA) or bypass surgery (BG) based on plaque echolucency

Chicago, Illinois, USA, June 2011, Society for Vascular Surgery Annual Meeting.

1. Primary Non-Synthetic AVFs (PAVF) for Long Term Venous access (LTVA): Are Proximal AVF Access Procedures Superior to Distal (DAVF) Access Interventions? A 5-Year Congruence Scrutiny Assessment Study

Bournemouth, UK, May 2011, ASGBI 2011, International Surgical Congress of the Association of Surgeons of Great Britain and Ireland.

1. Assessing the Impact of Patient Risk Factors and Methods of Wound Closure on Vascular Surgical Site Infection (VSSI) Rates

London, UK, April 2011, 33rd Charing Cross International Symposium, Vascular & Endovascular Controversies Update, Imperial College London

1. Primary non-synthetic AVFs (PAVF) for long term venous access (LTVA): Are proximal AVF access procedures superior to distal (DAVF) access interventions? A 5-Year congruence scrutiny assessment study
2. Disruptive endovascular technology with multilayer stents as a therapeutic option in the management a thoracoabdominal aortic aneurysms

Orlando, Florida, March 2011, Society for Clinical Vascular Surgery 39th Annual Symposium,

1. Fast Track Carotid Surgery Is The Gold Standard For High-risk Carotid Artery Intervention Five Year Cost-effectiveness & Quality Survival Comparison Between Carotid Endartrectomy, Carotid Angioplasty & Stenting Technique & Optimal Medical
2. Methicillin Resistant Staphylococcal Infections & Colonisation Rates & Their Consequences on Long Term Upshots to Vascular Patients Imparting to A Tertiary Referral Unit: A Seven Year Experience
3. Para Millenium High Risk AAA Saga: A Clinical Dilemma But Is Not A Major Concern For The Endovascular Specialist?
4. Challenging Case Presentation: A Novel Approach to management of Thoracoabdominal Aortic Aneurysm

Miami, Florida, January 2011. International Society of Endovascular Therapy, ISET 2011

38. Three-Year Outcomes of Excimer Laser-Assisted Angioplasty and Balloon Angioplasty in Tibial Arterial Occlusion TASC D^E

Sydney, Australia, December 2010. Endovascular Summit 2010

1. Challenging Case Presentations Endovascular Management of a complicated Chronic Type B Dissection with the application of multi-layer stent technology
2. Challenging Case Presentations: Multilayer stenting of a Thoraco-abdominal Aortic Aneurysm
3. Challenging Case Presentations: Redefining The Limit Of Endovascular Stenting

Washington D.C., USA, October 2010, American College of Surgeons 96th Annual Clinical Congress

1. Five-Year Irish Trial of CLI Patients with TASC II Type C/D Lesions Undergoing Subintimal Angioplasty or Bypass Surgery Based on Plaque Echolucency

Amsterdam, The Netherlands, September 2010. European Society of Vascular Surgery XXIV Annual Meeting

1. Fast track Carotid Surgery is the Gold Standard for High-risk (HRP) Carotid Artery Intervention: Five year Cost-effectiveness and Quality Stroke Free Survival Comparison between Carotid Endarterectomy (CEA), Carotid Angioplasty and Stenting Technique (CAST) and Optimal Medical Therapy (OMT) In Symptomatic Patients at a University Vascular Centre with Appraisal of the Contemporary Prose.

Galway, Ireland, June 2010. 8th Annual Western Vascular Institute Symposium

1. CEA Is the Procedure of Choice for Stroke in Evolution. Treatment with CAS Is Akin to Playing Russian Roulette.
2. Paramillennium High-Risk AAA Saga: A Clinical Dilemma But Is Not a Major Concern for the Endovascular Specialist.
3. Five-Year Prospective Study of Duplex Ultrasound Arterial Mapping (DUAM) as a Primary Modality in Management of Critical lower Limb Ischemia (CLI): Technical and Clinical Outcome after Bypass Surgery (BS) and Endovascular Revascularization (EvR).
4. Methicillin-Resistant Staphylococcal Infections (MRSA) and Colonization Rates and Their Long-Term Consequences for Vascular Patients Presenting to a Tertiary Referral Unit: A 7-Year Experience.
5. Supragenicular Bypass Using Cuffed Synthetic Grafts in Management of Critical Lower Limb Ischemia (CLI): A 4-Year Observational Parallel-Group Prospective Comparative Study.
6. Thermal Ablation Is a Primitive Way of Managing Superficial Vein Reflux.
7. Hyperbaric Oxygen Therapy Is More Clinically Efficacious and Cost-effective Compared to Compression Therapy in the Treatment of Chronic Venous Ulcers.
8. Case-Control Divergence of a Pivotal Study of Tinzaparin Alone versus Warfarin for Treatment of Acute Deep Venous Thrombosis and Pulmonary Embolism: Early Experience, Q-TWIST, and Paradigm Shift in Management of DVT in a Tertiary Referral Center.
9. To Ligate or Not to Ligate in Migrating Superficial Thrombophlebitis.
10. Filter-Protected CAS Is More Dangerous and Associated with More Procedure-Related Complications than Unfiltered CAS.
11. Pararenal Endovascular Aortic Repair Is Superior to Open Repair and Affords the Most Clinically Efficacious and Cost-Effective Outcome.
12. Early Experience with Chimney Thoracoabdominal Endografts.
13. Incidence of Concomitant Malignancy in AAA: 8-Year Experience.
14. Long-Term Follow-up of AAA Patients and Factors Determining Sac Shrinkage.
15. Vascular Surgeons Are More Experienced in Infragenicular Disease and Are Better Equipped to Treat These Unique Vessels.
16. Subintimal Angioplasty Is an Invaluable and Cost-effectiveTechnique in Experienced Hands.
17. There is always a Plan D for Limb Salvage.
18. Primary Nonsynthetic AVFs: Are Proximal AVF Access Procedures Superior to Distal Access Interventions? A 5-Year Congruence Scrutiny Assessment Study
19. Cardiovascular Antiaging: Can We Roll Back the Years? YES, WE CAN!
20. Do Statins Adversely Affect Glycemic Control in Nonobese Type 2 Diabetes Mellitus Patients? A Deplorable Bona Fide Conscious Clinical Scenario!
21. A Prospective Study of the Relevance of Global Vascular Bed Pathology in the Pattern of Management of Vascular Patients Referred to a Vascular Tertiary Referral Center: The Clinical Implications of the Presence of Asymptomatic Vascular Pathology for Outcome in Peripheral Arterial Disease (PVD), Abdominal Aortic Aneurysm (AAA), and Carotid (CAS) Intervention.
22. Endovenous Subadventitial Stripping of the Great Saphenous Vein: The 21st Century Graceful Solution.
23. A Successful Future for Vascular Specialists Extends beyond Device Design. How Can We Manage Our Future and Move Forward as a Sector? Bioconvergence.

Marseilles, France, June 2010. MEET 2010, Multidisciplinary European Endovascular Therapies Congress.

1. Practice of BTK angioplasty: Access, technique & tools for BTK angioplasty – Antegrade upsilateral approach
2. Cost-effectiveness and Quality of Life following Contemporary Management of Critical Lower Limb Ischaemia (CLI) in the femoro-popliteal segment. Randomization of CLI Patients with TASC C&D lesions to Subintimal Angioplasty (SIA) or Bypass surgery

Boston, Massachusetts, USA, June 2010, Society for Vascular Surgery Annual Meeting.

1. Sustained 5 Years Performance Analysis of Sequential Compression Biomechanical Device (SCBD) in Critical Limb Ischaemia (CLI) Patients with Un-reconstructable Peripheral Vascular Disease (PVD) vs Primary Amputation in a Tertiary Referral Vascular Centre With Quality of Time Without the Symptoms or Toxicity of the Disease (QTWiST)
2. Five-Year Experience with Pararenal Endovascular Aortic Repair (PEVAR) Without Fenestration. Clinical Efficacy, Reintervention Rates & Cost-effectiveness Compared With Open Surgical Repair (OSR) in a High Deliberare Practice Volume Centre.

Scottsdale, Arizona, USA, April 2010, Society of Clinical Vascular Surgery 38th Annual Symposium.

1. Sir Peter Samuels Award: A Mid to long term Experience of Clinical Efficacy and Cost per Quality-Adjusted -Life Years with Pararenal Endovascular Aortic Repair (PEVAR) without Fenestration for Para-renal AAA compared with Open Surgical Repair.
2. Does Topical Wound Oxygen (TWO2) Offer an Improved Outcome Over Conventional Compression Dressings (CCD) in the Management of Refractory Non-Healing Venous Ulcers (RVU)?
3. Challenging Case Presentation: Endovascular Management of Multiple Inflammatory Aneurysms associated with Hypereosinophilic Syndrome

Galway, Ireland, May 2009. 7th Annual Western Vascular Institute Symposium

1. Contemporary Management of Critical Lower Limb Ischaemia (CLI) in the femoro-popliteal segment. Randomization of CLI Patients with TASC C&D lesions to Subintimal Angioplasty (SIA) or Bypass surgery
2. Comparison of Endovenous Upward Perforate Invaginate Stripping (EUPIS), Downward Invaginate (DIS) and High-energy Endovenous LASER ablation (HE-EVLA) for Varicose Veins.
3. A Prospective Clinical and Quality of Life Analysis of Open Repair (OR), Endovascular Repair (EVAR) and Best Medical Treatment (BMT) in High-Risk Patients. Cost-effectiveness during Recession
4. Fast track Carotid Surgery is the gold standard for High-risk (HRP) Carotid Artery Intervention: Five year Cost-effectiveness and Quality Stroke Free Survival comparison between CEA, CAS and OMT
5. Five-year Experience with EVAR without Fenestration for Juxtarenal. Clinical Efficacy, Reintervention Rates & Cost-effectiveness Compared with Open Repair in High Deliberare Practice Volume centres
6. Endovascular Aneurysm Repair is the Preferred Option for Ruptured AAA
7. Excellence in Translational Infrastructure – The Importance of Keeping Research and Innovation within the Clinical Setting. Why Vascular Disease is an Ideal Model for a Translational Centre

Florida, U.S.A., March 2009. Society for Clinical Vascular Surgery, 37th Annual Symposium

1. Five Years Prospective Study of Duplex Ultrasound Arterial Mapping (DUAM) as a Primary Modality in Management of Critical Lower Limb Ischemia (CLI). Technical and Clinical Outcome after Bypass Surgery (BS) and Endovascular Revascularisation (EvR).
2. Cool Excimer Laser Assisted Angioplasty (CELA) vs Tibial Balloon Angioplasty (TBA) in Endovascular (EvR) Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI) TASC DE.A Pivotal Observational Analogy Congregate Proportional Analysis over 36 Months; Six L Trial.
3. Aorto-Uniliac vs Bifurcated Endovascular Aortic Repair: Technical Success, Secondary Intervention Rate and Quality-Adjusted Cost Analysis.

Nice, France, September 2008. European Society for Vascular Surgery 2008 Meeting.

1. Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST) in the Management of Refractory Non-Healing Venous Ulcers (RVU). Topical Wound Oxygen (TWO2) Versus Conventional Compression Dressings (CCD); A Parallel Observational Pivotal Study.

Cannes, France, June 2008. MEET congress Multi-disciplinary European Endovascular Therapy.

1. Tibial Balloon Angioplasty (TBA) Vs Cool Eximer Laser Assisted Angioplasty (CELA) in Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI): An Observational Parallel Group Comparative Study.

Galway, Ireland, May 2008. 6th Annual Western Vascular Institute Symposium.

1. Advances in Ablation of the Greater Saphenous Vein in the 21st Century: Development of an Endovenous Upward Perforate Invaginate (EUPIN) Stripping Device and Procedure Based on Best Medical Practice.
2. Preclinical Medical Device Testing and the Potential of Noninvasive Imaging.
3. Carotid Artery Intervention in High-Risk Patients: Carotid Artery Stenting (CAS) under Neuroprotection, Carotid Endarterectomy (CEA), and Best Medical Therapy (BMT) for Symptomatic Patients with Low Grayscale Median (GSM).
4. Contemporary Trends in Carotid Intervention: the 21st Century Approach to Carotid Endarterectomy, Carotid Artery Stenting under Neuro Protection and Optimal Medical Treatment.
5. Subintimal Angioplasty (SIA) versus Bypass Surgery (BS) in TASC C and D Lesions in the Femoropopliteal Segment: Randomization of CLI Patients according to Plaque Echolucency: A 5-Year Prospective Study.
6. Prevalence and Correlation of Hyperhomocysteinemia to Amputation-Free Survival (AFS), Major Adverse Events (MAE), and Mortality after Intervention for Critical Lower Limb Ischemia (CLI) in Patients with Peripheral Vascular Disease (PVD).
7. Tibial Balloon Angioplasty (TBA) versus Cool Eximer Laser–Assisted Angioplasty (CELA) in Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischemia (CLI): An Observational Parallel-Group Comparative Study.
8. The Influence of Deliberate Practice Volume (DPV) on the Slope of the Learning Curve for Vascular Training in a Tertiary Referral Center: A Prospective Analysis.
9. Paradigm Shift in Open Pararenal Aortic Aneurysm Repair in the Endovascular Era: 5 Years’ Experience.
10. The Role of Prostaglandin I₂ Infusion in Elective Open Repair of Abdominal Aortic Aneurysm.
11. Continuous Autotransfusion System (C.A.T.S.) in Open Abdominal Aortic Aneurysm Repair: 9 Years’ Experience in a Tertiary University Vascular Center.
12. Double-Blinded Randomized Trial of Thin versus Ultrathin Dacron Patching in Carotid Endarterectomy (CEA): Short-Term Technical and Clinical Outcome.
13. A Prospective Clinical, Economic, and Qualityof-Life Analysis Comparing Endovascular Aneurysm Repair (EVAR), Open Repair, and Best Medical Treatment in High-Risk Patients with Abdominal Aortic Aneurysms Suitable for EVAR: The Irish Patient Trial.
14. Aortouniliac versus Bifurcated Endovascular Aortic Repair: Technical Success, Secondary Intervention Rate, and Quality-Adjusted Cost Analysis.
15. Survival Rate of Octogenarians versus Younger Patients following Abdominal Aortic Aneurysm Repair in a Tertiary Referral Center.
16. Derivation and Validation of a Customized Risk Scoring Index for Abdominal Aortic Aneurysm Patients.
17. A Prospective Comparative Study of Preoperative Duplex Ultrasound Arterial Mapping (DUAM), Digital-Subtraction Angiography (DSA), and Magnetic Resonance Angiography (MRA) in Critical Lower Limb Ischemia (CLI) prior to Endovascular Revascularization (EvR): Clinical, Technical, and Economic Outcome.
18. Last-Ditch Therapy in Unreconstructable Peripheral Arterial Disease in Patients with Critical Limb Ischemia: A 4-Year Experience.
19. Does the Stake of Reamputation Justify Initial Transmetatarsal Foot Amputation (ITMA) over Initial Digital Amputation (IDA)? A Comparative Longitudinal 5-Year Logistical Study of ITMA versus IDA for Critical Limb Ischemia (CLI) Postrevascularization.
20. Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Celiac Ganglion Sympathectomy (CGS): Case Series and Literature Review.
21. Comparison of Endovenous Upward Perforate Invaginate Stripping (EUPIS), Downward Invaginate (DIS), and High-Energy Endovenous LASER Ablation (HE-EVLA) for Varicose Veins: Factors Influencing Complication Rate, Long-Term Recurrence, Quality of Life, and Cost-Effectiveness.
22. Early Results of Topical Wound Oxygen (TWO₂) Therapy in the Management of Refractory Nonhealing Venous Ulcers (RVU): Superior Role over Conventional Compression Dressings (CCD).
23. Recombinant Activated Factor VII (rFIIa) in Critical Vascular Surgery Bleeding: 5 Years’ Experience.
24. Scalenus Anterior Resection Assessment by Disability of Arm Shoulder and Hand (DASH) Scoring in the Management of Thoracic Outlet Syndrome.
25. Femoral Artery Access in Arterial Reconstructive Surgery: How to Minimize Groin Infection: 5-Year Results.
26. Contemporary Measures to Reduce Surgical Site Infection Rates.

Las Vegas, Nevada, March 2008, Society for Clinical Vascular Surgery 36th Annual Symposium.

1. Subintimal Angioplasty (SIA) versus Bypass for Critical Lower Limb Ischaemia (CLI) in Patients with TASC C and D Lesions. 5-year Result.
2. Quality-Time spent Without Symptoms or Toxicity (Q-TWiST) and cost-effectiveness of Endovenous Laser therapy (EVLT) Vs conventional level II sapheno-femoral junction ligation (SFJ) and LSV Stripping (OLS) for primary Varicose Veins (VVS). A prospective Pivotal Study.

Denver, Colorado, USA, February 2008, Peripheral Vascular Surgery Society Winter Meeting

1. The Role of Prostaglandin I2 Infusion in Elective Open Repair of Abdominal Aortic Aneurysm.
2. Subintimal Angioplasty (SIA) vs Bypass Surgery (BS) for Critical Lower Limb Ischaemia in Patients with TASC C and D Lesions: 5-year Prospective Observational Comparative Study.

Hollywood, Florida, January 2008. International Society of Endovascular Therapy, ISET 2008

1. Subintimal Angioplasty (SIA) vs Bypass for Critical Lower Limb Ischemia in Patients with TASC C and D Lesions: 5-Year Result.
2. Prevalence and Correlation of Hyperhomocysteinemia to Amputation Free Survival (AFS), Major Adverse Events (MAE) and Mortality after Intervention for Critical Lower Limb Ischaemia (CLI) in Patients with Peripheral Vascular Disease (PVD).
3. Derivation and Validation of a Customized Risk Scoring Index for Abdominal Aortic Aneurysm Patients.

Manchester, UK, November 2007. Annual Meeting of the Vascular Society of Great Britain and Ireland,

1. Subintimal angioplasty (SIA) vs Bypass for critical lower limb ischemia in patients with TASC C and D lesions: 5-year result.
2. Prevalence and Correlation of Hyperhomocysteinemia to Amputation Free Survival (AFS), Major Adverse Events (MAE) and Mortality after Intervention for Critical Lower Limb Ischaemia (CLI) in Patients with Peripheral Vascular Disease (PVD).
3. Topical Wound Oxygen (TWO₂) Versus Conventional Compression Dressings (CCD) in the Management of Refractory Non-Healing Venous Ulcers( RVU); A Parallel Observational Pivotal Study in CEAP six       category patients.

Cannes, France, June 2007. MEET congress Multi-disciplinary European Endovascular Therapy.

1. The down slope of endovenous laser therapy for primary varicose veins. Technology is still lacking.

Baltimore, Maryland, USA, June 2007. Society for Vascular Surgery. Annual Vascular Meeting.

National

Limerick, March 2012. Sylvester O’Halloran Surgical Meeting,

1. Contrast induced nephropathy and Chronic Kidney Disease (CIN/CKD) as a consequence of utilising non ionic isoosmolar contrast media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study
2. Technical superiority and clinical excellence of Duplex Ultrasound Arterial Mapping (DUAM) vs Magnetic Resonance Angiogram (MRA), as the sole imaging modality in Bypass Surgery (BS) and Endovascular Revascularisation (EvR) For Critical Lower Ischemia (CLI) patients. 6 years comparative study in a tertiary referral vascular centre
3. The effects of normalising hyperhomocysteinemia on operative outcome in patients undergoing intervention for peripheral vascular disease

Galway, September 2011, XXXVIth Sir Peter Freyer Memorial Lecture & Surgical Symposium

4. Supraclavicular Scalenectomy in the Management of Thoracic Outlet Syndrome; Functional Outcome as Assessed using the DASH Scoring System
5. Para Millennium High Risk AAA saga: A Clinical Dilemma but is Not a Major Concern for the Endovascular Specialist!
6. Thoracic Abdominal Endovascular Aneurysm Repair (TEVAR) in the Management of Acute Aortic Syndrome (AAS). An Early Experience with De-Branching, Chimney Techniques and Multi-Layer Stenting
7. Prevalence of Malignancies Post AAA Repair: An Eight Years Comparable Longitudinal Study of EVAR vs Open Repair (OP) in a Tertiary Referral University Vascular Centre
8. Assessing Factors affecting Surgical Site Infection Rates in Vascular Patients attending a Tertiary Specialist Centre

Galway May 2011, Clinical Presentations for Fred Given Medal

9. Supraclavicular Scalenectomy in the Management of Thoracic Outlet Syndrome – Functional Outcome as Assessed using the Disability of Arm, Shoulder and Hand (DASH) Scoring System
10. Assessing Factors affecting Surgical Site Infection Rates in Vascular Patients attending a Tertiary Specialist Centre

Galway, May 2011, WREN 2011, Western Region Education Network

11. Disruptive endovascular technology with multilayer stents as a therapeutic option in the management a thoracoabdominal aortic aneurysms

Naas, Co Kildare, April 2011, Joint Meeting of the Irish Association of Vascular Surgeons and Northern Ireland Vascular Society

12. Para Millenium High Risk AAA Saga: A Clinical Dilemma But Is Not A Major Concern for The Endovascular Specialist?

Dublin, November 2010 Winner RAMI Clinical Case Conference:

13. TEVAR Hybrid Repair for a Challenging Thoracoabdominal Aortic Aneuryms

Galway, September 2010. 35th Sir Peter Freyer Memorial Lecture and Surgical Symposium

14. Management of Complex Aortic Pathologies Using Minimal Invasive Surgical Techniques. Early Encounter with TEVAR & Hybrid Surgery
15. Assignment of Endovascular Surgery to the Management of Combined Arterial and Venous Ulcers (CAVUS). A Prospective 36 Months Clinical Study

Ballinasloe, Co Galway, May 2010, WREN 2010, Western Region Education Network

16. Endovascular management of Multiple Aneurysms Associated with Hypereosinophilia Syndrome

Limerick, March 2010. Sylvester O’Halloran Surgical Meeting,

17. Initial encounter with thoracic endovascular aneurysm repair (TEVAR) for thoraco-abdominal Pathology (TAP) in a tertiary referral vascular centre. A technical challenge of debranching, chimneys, snorkel endovascular grafts in the era of hybrid surgery?

Galway, September 2009. 34th Sir Peter Freyer Memorial Lecture and Surgical Symposium

18. Six L Trial; Cool Excimer Laser Assisted Angioplasty (CELA) Versus Tibial Balloon Angioplasty (TBA) in Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI) TASC D.
19. Technical and Clinical Excellence of Duplex Ultrasound Arterial Mapping (DUAM) as the Sole Imaging Modality in Bypass Surgery (BS) and Endovascular Revascularisation (EvR).
20. Five-Year Experience with EVAR without Fenestration for Juxtarenal, Clinical Efficacy, Reintervention Rates and Cost Effectiveness compared with Open Repair in High deliberate Practice Volume Centres.

Dublin, February 2009: The Henry Hutchinson Medal for the 3rd annual intercollegiate RCSI surgical case presentations.

21. First Place: Complex Carotid Surgery. A pain in the neck.

Galway, September 2008. 33rd Sir Peter Freyer Memorial Lecture and Surgical Symposium

22. Does the risk of Re-Amputation Justify Initial Trans-metatarsal Foot amputation (ITMA) over initial Digital Amputation (IDA)? A comparative longitudinal 5 years logistical study of ITMA Vs IDA for critical limb ischaemia (CLI) post revascularisation.

Galway, September 2007. 32nd Sir Peter Freyer Memorial Lecture and Surgical Symposium

23. Plenary Session: Technical and clinical outcome in Para-Renal Aortic Repair with Single Suprarenal Artery clamping? A parallel group observational contrast study of elective /Emergency Supra-Renal Aortic aneurysm Repair (SRAR) and Infrarenal Aortic Aneurysm Repair (IRAR) in a tertiary referral university centre.
24. Prevalence and Correlation of Hyperhomocysteinaemia to Major Adverse Events (MAE) after Intervention for Critical Lower Limb Ischaemia
25. Topical Wound Oxygen (TWO₂) Versus Conventional Compression Dressings in the Management of Refractory Non-Healing Venous Ulcers; A Parallel Observational Pivotal Study

Galway, September 2006 31st Sir Peter Freyer Memorial Lecture and Surgical Symposium,

26. Plenary Session: Technical and clinical outcome in Para-Renal Aortic Repair with Single Suprarenal Artery clamping? A parallel group observational contrast study of elective /Emergency Supra-Renal Aortic aneurysm Repair (SRAR) and Infrarenal Aortic Aneurysm Repair (IRAR) in a tertiary referral university centre.
27. Supragenicular Bypass using Cuffed Synthetic Grafts in Management of Critical Lower Limb Ischaemia (CLI): An Observational Parallel Group Prospective Comparative Study.
28. Derivation and Validation of a Predictive Index of Morbidity and Mortality in Abdominal Aortic Aneurysm (AAA) Repair. A Comparison with Physiological and Operative Severity Score for Enumeration of Morbidity and Mortality (Possum, Modified Portsmouth Possu, Lee Revised Cardiac Risk Index and European System for Cardiac Risk Evaluation (Euroscore)
29. Role of Prostaglandin E2 Infusion in Improved Peri-Operative Outcome in Open Abdominal Aortic Aneurysm Repair
30. Carotid Artery Intervention in High-Risk Patients; A Prospective Observational Study of Carotid Artery Stenting with Neuro-Protection (CAST) and Carotid Endarterectomy with Patching (CEA)

RAMI Registrar’s Prize Meeting 2006 (Surgical Section), Royal College of Surgeons in Ireland.

31. Haemoglobin A1C (HbA1C) in Non-diabetic and Diabetic Vascular Patients. Is HbA1C an Independent Risk Factor and Predictor of Adverse Outcome?

Limerick, March 2006. Sylvester O’Halloran Surgical Meeting,

32. An Observational Parallel Group Comparison Study of Duplex Ultrasound Arterial Mapping (DUAM) with Magnetic Resonance Angiography (MRA) and Conventional Angiography (CA) as Sole Pre-operative Investigative Tools for Endovascular revascularizations.
33. Haemoglobin A1C (HbA1c) in nondiabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?

Galway 2006. Annual Meeting Biomedical Engineering Institute of Ireland

34. Do Cerebral Protection Devices perform effectively? Met analysis and critique of licensed cerebral protection devices..
35. Analysis of Abdominal Aortic Aneurysm (AAA) geometry using Reconstructed 3- Dimensional Models of Patient-specific Aneurysms – A preliminary prospective study of 31 cases.
36. Computer simulation to evaluate the efficacy of intermittent pneumatic compression on systemic blood circulation.

Galway, September 2005. XXXXth Sir Peter Freyer Memorial Lecture and Surgical Symposium.

37. A comparison of open (OR) and endovascular abdominal aortic aneurysm repair (EVAR) with best medical treatment (BMT). Has the availability of EVAR expanded our indications for intervention, and improved survival? (Plenary Session)
38. Demographic changes in the level and numbers of amputees since the introduction of Subintimal Angioplasty (SIA). Influence of Deliberate Practice on Limb Salvage Rates and Long-term in Critical Lower Limb Ischaemia (CLI): A 15-years experience.
39. A Prospective Observational Study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in High-Risk Patients. Short term results.
40. A Biomechanical device for Non-operative management of Critical limb Ischemia (CLI): Initial short term experience.
41. An Observational Parallel Group Comparison Study of Duplex Ultrasound Arterial Mapping (DUAM) with Magnetic Resonance Angiography (MRA) and Conventional Angiography (CA) as Sole Pre-operative Investigative Tools for Endovascular revascularizations
42. Haemoglobin A1C (HbA1c) in nondiabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome?
43. A Prospective Observational Longitudinal Study of Pharmacological Manipulation in Abdominal Aortic Aneurysm (AAA) Surgery: Are Statins, Beta-blockers and Anti-platelet Therapy the Best Combination?
44. Video Presentation: Life of a Trainee Vascular Surgeon. E Ryan, P King J Diener, S Sultan.

Galway, 2005. Irish Angiology Society conference

45. A Prospective Observational Study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in High-Risk Patients. Technical and Clinical Outcome.
46. A Biomechanical device for Non-operative management of Critical limb Ischemia (CLI): Initial short term experience.
47. Haemoglobin A1c (HbA1c) in nondiabetic vascular patients. is hba1c an independent risk factor and predictor of adverse outcome?.
48. Pharmacological Manipulation in Abdominal Aortic Aneurysm (AAA) Surgery: Are Statins, Beta-blockers and Anti-platelet Therapy the Best Combination? A Prospective Observational Longitudinal St
49. A Double-Blinded Randomized Trial of Thin versus Ultra-thin Dacron Patching during Carotid Endarterectomy (CEA): Mid-term Results.
50. Continuous Auto-Transfusion System (CATS) in Open AAA repair: A seven-year experience.
51. A Prospective Comparative Analysis of Distaflo versus Gortex grafts in infrainguinal supragenicular vascular disease in critical limb ischaemia.

Limerick, March 2005 Sylvester O’Halloran Surgical Meeting,

52. A prospective observational study of Carotid artery Stenting (CAST) under neuro-protection and carotid endarterectomy (CEA) in high risk patients. Technical and Clinical Outcome.

Dublin, 2005. RAMI Registrar’s Prize Meeting 2005 (Surgical Section),

53. A Comparison of EVAR & Open Repair with Best Medical Treatment. Has the availability of EVAR expanded our indications for intervention & improved Patient survival?

Galway, September 2004. XXXIXth Sir Peter Freyer Memorial Lecture and Surgical Symposium.

54. The influence of Subintimal Angioplasty on Limb Salvage in Lower Limb Critical Ischaemia: 15-years experience.

Limerick, March 2004 Sylvester O’Halloran Surgical Meeting,

55. Patching of carotid artery after endarterectomy with Hemashield collagen-impregnated Darcon thin and ultrathin patch: a 24-month, retrospective, randomised, double-blinded study.
56. Carotid angioplasty and stenting versus carotid endarterectomy: early results of an observational parallel group study

Galway, September 2003. XXXVIIIth Sir Peter Freyer Memorial Lecture and Surgical Symposium.

57. Outcome of primary revascularisation in lower limb critical ischaemia. A retrospective study in a tertiary referral vascular centre.
58. A comparative parallel group study with and without the ‘magic bullet’ in the perioperative and postoperative period for abdominal aortic aneurysms surgery and femoral popliteal segment revascularisation. Does the ‘magic bullet’ improve the 30-day morbidity and mortality outcome?
59. Does intravenous iloprost trometanol by Infusomat® have a role in the immediate postoperative period of abdominal aortic surgery. A prospective non-randomised clinical trial.
60. Adeno-associated, virus-mediated gene delivery to vascular cells in the rabbit carotid artery module: a controlled, randomised clinical trial.

Limerick, March 2003 Sylvester O’Halloran Surgical Meeting,

61. Opportunities in vascular surgery: endovascular intervention of the aorto-iliac and femoral-popliteal segments. A comparative parallel group study of bypass surgery and angioplasty.

Limerick, March 2001. Sylvester O’Halloran Surgical Scientific Meeting

62. Transfemoral endoluminal aortic management (TEAM) versus open surgical repair (or) in-patients with infra-renal abdominal aortic aneurysms (AAA) who are suitable for both techniques. Technical and clinical outcome.
63. Endovascular approach to aneurysm repair protects patients from postoperative systemic immune inflammation.
64. Efficacy and durability of above knee Femoro-popliteal bypass for critical limb ischaemia.

Galway September 2000. XXIV Sir Peter Freyer Lecture and Surgical Symposium

65. Percutaneous duplex ultrasound guided injection of thrombin. a new modality in the management of femoral artery pseudo-aneurysms.
66. The Impact Of Percutaneous Transluminal Angioplasty On Infra-Inguinal Bypass For Critical Limb Ischaemia.
67. T-cell activation after Endovascular repair of abdominal aortic aneurysm is   diminished compared to open repair.

Dublin, April 2000. Spring Meeting of the Society of Vascular Technologist of Ireland.

68. Recent Advances in abdominal aortic Surgery.

Limerick, March 1999. Sylvester O’Halloran Surgical Scientific Meeting

69. Ruptured abdominal aortic aneurysm: a twenty-year experience.
70. Over-sizing of the covered stent graft and suprarenal spare-springs are important in diminishing the incidence of endoleak in transfemoral endoluminal aortic management [TEAM] for infra-renal abdominal aortic aneurysms.

Galway September 1999. XXIII Sir Peter Freyer Lecture and Surgical Symposium

71. Transfemoral Endoluminal Aortic Surgery: A Minimal Invasive Approach to Abdominal Aortic Surgery.

Limerick, March 1999. Sylvester O’Halloran Surgical Scientific Meeting

72. Is Stenting of the Superficial Femoral Artery Justified?
73. Popliteal Aneurysms: To treat or not to treat.

Galway , September 1998. XXII Sir Peter Freyer Lecture and Surgical Symposium

74. Trans peritoneal Trans aortic Approach in Inflammatory Aortic Aneurysms. Report of thirty-two cases And a review of literature.
75. Stenting of the Superficial femoral Artery: Results of 171 cases

Limerick, March 1998. Sylvester O’Halloran Surgical Scientific Meeting

76. A critical reappraisal of thrombolysis in a specialist vascular unit.
77. Transfemoral Endoluminal Aortic Management; A minimally invasive option in aortic intervention

Dublin, November 1997. Royal Academy of Medicine of Ireland. President’s Prize.

• Case Report of an Aorto-duodenal and Aorto-Cava fistula with an accessory left Renal Artery Aneurysm Presenting with heart failure and chronic anemia due to haematemesis.

Limerick, March 1997. Sylvester O’Halloran Surgical Scientific Meeting

79. Initial experience with the angiomed memotherm stent in femoro-popliteal occlusive disease.
80. Initial experience with aortic stenting for aorto-iliac occlusive disease.

Dublin, December 1996. First Surgical Symposium at the Royal Academy of Medicine

81. Adjuvant Carotid Angioplasty and stenting case report.
82. Percutaneous transluminal angioplasty in management of retroperitoneal fibrosis.

Galway, September 1996 XXIst. Sir Peter Freyer Lecture and Surgical Symposium.

83. Short and mid term results of Infrainguinal angioplasty and stenting.
84. Limb salvage using the Miller Cuff with Infrainguinal by passes.

Galway, September 1995 XXth. Sir Peter Freyer Lecture and Surgical Symposium.

85. Anatomical Variation of the Sapheno-femoral junction.

Limerick, Ireland, March 2011, Sylvestor O’Halloran Surgical Meeting

72. Assessing the Impact of techniques of Wound Closure on Vascular Surgical Site Infection Rates.

Miami Florida, January 2011. International Society of Endovascular Therapy, ISET 2011

73. Three-Year Outcomes of Excimer Laser-Assisted Angioplasty and Balloon Angioplasty in Tibial Arterial Occlusion TASC D^E
74. Clinical Effectiveness of Endovascular Repair without Fenestration for Para-Renal Abdominal Aortic Aneurism (AAA) Compared with Open Repair
75. Prevalence of Malignancy after Abdominal Aortic Aneurysm (AAA) Repair: Eight-Year Longitudinal Study of Endovascular Aortic Repair (EVAR) vs Open Repair in a Tertiary Center

Milan, Italy, October 2010, 10th International Vascular and Endovascular Course (IVEC): Emerging Technologies, New Achievements and Future Perspectives in Endovascular Interventions/3rd European Congress of the International Society for Vascular Surgery (ISVS)

76. Primary Non-synthetic AVFs (PAVF) for Long Term Venous Access (LTVA): Are Proximal AVF Access Procedures Superior to Distal (DAVF) Access Interventions? A 5-Year Congruence Scrutiny Assessment Study.
77. Supragenicular Bypass Using Cuffed Synthetic Grafts in Management of Critical Lower Limb Ischaemia (CLI) for Patients Unsuitable for Endovascular Revascularisation (EvR) in TASC II D Lesions: A 6 Year Observational Three Parallel Groups( ePTFE, Distaflo® ,Dynaflo® grafts) Prospective Comparative Study with Quality Adjusted Time Spent Without Symptoms of Disease or Toxicity of Treatment (Q-TWiST).
78. Technical Superiority and Clinical Excellence of Duplex Ultrasound Arterial Mapping (DUAM) vs Magnetic Resonance Angiogram (MRA), as the Sole Imaging Modality in Bypass Surgery (BS) and Endovascular Revascularisation (EvR) For Critical Lower Ischemia (CLI) Patients. 6 Years Comparative Study in a Tertiary Referral Vascular Centre.
79. Cardiovascular Burden is More Treacherous Than any Neoplastic Pathology; Prevalence of Malignancies Post AAA Repair: an Eight Years Observational Study of EVAR vs Open Repair
80. Preoperative Vascular Screening and its Clinical Implications in the Presence of Aortic, Carotid and Peripheral Pathology for the Strategic Certitude for Vascular Surgery Patient’s Outcome

Washington D.C., USA, October 2010, Diabetic Limb Salvage Conference, Georgetown University Hospital.

81. A 5 Years parallel observation study of the Use of Sequential Compression Biomechanical Device in Critical Limb Ischaemia

Washington D.C., USA, October 2010, American College of Surgeons 96^th Annual Clinical Congress

82. A Mid to Long-Term Experience of Clinical Efficacy and Cost per Quality-Adjusted Life Years with Pararenal Endovascular Aortic Repair (PEVAR) without Fenestration for Para-renal AAA compared with Open Surgical Repair.
83. Cool Excimer Laser Assisted Angioplasty (CELA) vs. Tibial Balloon Angioplasty (TBA) in Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI) TASC DE. A Pivotal Observational Analogy Congregate Proportional Analysis over 48 Months “Six L Trial “.
84. A Three-Year Experience with Technical and Clinical Outcome and Quality-Adjusted Time Spent without Symptoms of Disease and Toxicity of Treatment (Q-TWiST) of Topical Wound Oxygen in Comparison with Conventional Compression Dressings in the Management of Refractory Non-Healing Venous Ulcers.

Waterford, October 2010, Waterford Surgical Meeting

85. Assessing the Impact of patient Risk Factors and Methods of Wound Closure on Vascular Surgical Site Infection (VSSI) Rates

Boston, USA, June 2010, Society of Vascular Surgery Annual Meeting

86. Carotid Artery Endarterectomy (CEA) for Stroke in Evolution (SIE): Technical and Long-term Clinical Outcome in a Tertiary Referral Vascular Centre. When to Master Silence?
87. The 6L Irish Pivotal Trial Comparing Three-Year Outcomes of Cool Excimer Laser Assisted Angioplasty (CELA) and Tibial Balloon Angioplasty (TBA) in Management of Infragenicular Tibial Arterial Occlusion in Critical Lower Limb Ischaemia (CLI) TASC D E .
88. Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Ganglion Sympathectomy (CGS) for Chronic Mesenteric Ischaemia (CMI). Procedural, Clinical and Enduring Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST).
89. Does Topical Wound Oxygen (TWO2) Offer an Improved Outcome Over Conventional Compression Dressings (CCD) in the Management of Refractory Non-healing Venous Ulcers (RVU)? Three-Year Technical and Clinical Outcome and Midterm Results With Quality-Adjusted Time Spent Without Symptoms of Disease and Toxicity of Treatment (Q-TWiST).

Marseilles, France, June 2010 MEET 2010, Multidisciplinary European Endovascular Therapies Congress.

90. Comparison of Endovenous Upward Perforate Invaginate Stripping (EUPIS), Downward Invaginate (DIS) and High-energy Endovenous LASER ablation (HE-EVLA) for Varicose Veins.
91. A prospective comparative study of pre-operative Duplex Ultrasound Arterial Mapping (DUAM), Digital-Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA) in Critical Lower Limb Ischaemia (CLI) prior to Bypass Surgery (BS) or Endovascular.
92. Fast track Carotid Surgery is the gold standard for High-risk (HRP) Carotid Artery Intervention: Five year Cost-effectiveness and Quality Stroke Free Survival comparison between CEA, CAS and OMT.

Limerick, Ireland, March 2010, Sylvestor O’Halloran Surgical Meeting

93. The use of sequential compression biomechanical device in critical limb ischemia patients with un-re-constructable peripheral vascular disease. A 5 years experience in a tertiary referral vascular centre.

San Francisco, USA, September 2009. TCT 2009. Transcatheter Cardiovascular Therapeutics

94. Five-year Experience with EVAR without Fenestration for Juxtarenal. Clinical Efficacy, Reintervention Rates & Cost-effectiveness Compared with Open Repair in High Deliberare Practice Volume centres.

Galway, September 2009. 34th Sir Peter Freyer Memorial Lecture and Surgical Symposium

95. Aorto-Uniliac Vs Bifurcated Endovascular Aortic Repair: Technical Success, Secondary Intervention Rate and Quality-adjusted cost analysis.
96. Improving Clinical and Haemodynamic Outcome in Critical Lower Limb Ischaemia with a Sequential Compression Biomechanical Device.

New Orleans, USA, July 2009, New Cardiovascular Horizons

97. Improving Clinical and Haemodynamic outcome in Critical Lower Limb Ischaemia with a Sequential Compression Biomechanical Device,
98. Assignment of Endovascular surgery to the management of Combined Arterial and Venous Ulcers (CAVUS). A prospective 36 Months Clinical study
99. Contemporary Management of Critical Lower Limb Ischaemia (CLI) in the femoro-popliteal segment. Randomization of CLI Patients with TASC C&D lesions to Subintimal Angioplasty (SIA) or Bypass surgery
100. Does Topical Wound Oxygen (TWO2) Offer an Improved Outcome Over Conventional Compression Dressings (CCD) in the Management of Refractory Non-Healing Venous Ulcers (RVU).

Denver, Colorado, USA, June 2009, Society for Vascular Surgery Annual Meeting.

101. Contemporary Management of Critical Lower Limb Ischaemia (CLI) with TASC C and D femoro-popliteal lesions. Five-Year Comparative Trial of Subintimal Angioplasty (SIA) or Bypass surgery (BS).

Nice, France, September 2008. European Society for Vascular and Endovascular Surgery Annual Meeting

102. Contemporary Management of Critical Lower Limb Ischaemia (CLI) in the femoro-popliteal segment. Randomization of CLI Patients with TASC C and D lesions to Subintimal Angioplasty (SIA) or Bypass surgery (BS) in concurrence to plaque echolucency: 5-year Irish Trial.

Las Vegas, Nevada, March 2008, Society for Clinical Vascular Surgery 36^th Annual Symposium.

103. A prospective comparative study of pre-operative Duplex Ultrasound Arterial Mapping (DUAM), Digital-Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA) in Critical Lower Limb Ischaemia (CLI) prior to Endovascular Revascularization (EvR).Clinical, Technical and Economic outcome.

Washington DC, Maryland, February 2008. Cardiovascular Revascularization Therapies, CRT 2008

104. Carotid Artery Intervention In High-risk Patients; A Prospective Parallel Group Observational Study Of Carotid Artery Stenting (CAS) Under Neuro-protection, Carotid Endarterectomy (CEA) And Best Medical Therapy (BMT).
105. Paradigm Shift in Management Of Critical Lower Limb Ischaemia (CLI) In The 21^St Randomization Of CLI Patients With TASC C And D Lesions To Subintimal Angioplasty (SIA) Or Bypass Surgery (BS) In Concurrence To Plaque Echolucency In The Femoro-popliteal Segment. The 5-year Irish Trial.

Hollywood, Florida, January 2008. International Society of Endovascular Therapy, ISET 2008

106. Subintimal Angioplasty (SIA) vs Bypass for Critical Lower Limb Ischemia in Patients with TASC C and D Lesions: 5-Year Result.
107. Prevalence and Correlation of Hyperhomocysteinemia to Amputation Free Survival (AFS), Major Adverse Events (MAE) and Mortality after Intervention for Critical Lower Limb Ischaemia (CLI) in Patients with Peripheral Vascular Disease (PVD).
108. Derivation and Validation of a Customized Risk Scoring Index for Abdominal Aortic Aneurysm Patients.
109. A Prospective Comparative Study of Pre-Operative Duplex Ultrasound Arterial Mapping (DUAM), Digital-Subtraction Angiography (DSA) and Magnetic Resonance Angiography (MRA) in Critical Lower Limb Ischaemia (CLI) Prior to Endovascular Revascularization (EvR).Clinical, Technical and Economic Outcome.
110. Quality-Time Spent without Symptoms or Toxicity (Q-TWiST) and Cost-Effectiveness of Endovenous Laser Therapy (EVLT) vs Conventional Level II Sapheno-Femoral Junction Ligation (SFJ) and LSV Stripping (OLS) for Primary Varicose Veins (VVS). A Prospective Pivotal Study.
111. Management of Severe Carotid Artery Disease in High-Risk Patients; a Prospective Observational Parallel Group Study of Carotid Artery Stenting with Neuro-Protection (CAST), Carotid Endarterectomy with Patching (CEA) and Best Medical Treatment.

Manchester, UK, November 2007. Annual Meeting of the Vascular Society of Great Britain and Ireland,

112. Scalenus Anterior Resection assessment by disability of arm, should and hand (DASH) scoring in the management of Thoracic Outlet Syndrome.

New York, November 2007. 34^th Annual Veith symposium

113. Management of Critical Lower Limb Ischaemia in the 21^st Randomization of Patients with TASC D lesions to Subintimal Angioplasty or Bypass surgery depending on plaque echoloucency in the occluded femoro-popliteal segment. The 5-year Irish Trial.
114. Technical and clinical outcome in Para-Renal Aortic Repair with Single Suprarenal Artery clamping in a tertiary referral university centre.
115. Quality-Time spent Without Symptoms or Toxicity (Q-TWiST) and cost-effectiveness of Endovenous Laser therapy (EVLT) Vs conventional level II sapheno-femoral junction ligation (SFJ) and LSV Stripping (OLS) for primary Varicose Veins (VVs). A prospective Pivotal Study; Technology is still lacking.
116. Topical Wound Oxygen (TWO₂) Versus Conventional Compression Dressings (CCD) in the Management of Refractory Non-Healing Venous Ulcers (RVU); A Parallel Observational Pivotal Study.
117. Derivation and Validation of a Customized Risk Scoring Index for Abdominal Aortic Aneurysm Patients.

Galway, September 2007. 32nd Sir Peter Freyer Memorial Lecture and Surgical Symposium

118. Laser-assisted Angioplasty for Patients with Critical Limb Ischemia.
119. Management of Median Arcuate Ligament Syndrome (MALS) with Decompression and Coeliac Axis Sympathectomy (CAS): Five Year Experience.

Orlando Florida, March 2007. Society for Clinical Vascular Surgery, 35th Annual Symposium on Vascular Surgery

120. Derivation and Validation of a Customized Risk Scoring Index for Abdominal Aortic Aneurysm Patients.
121. Technical and clinical outcome in Para-Renal Aortic Repair with Single Suprarenal Artery clamping in a tertiary referral university centre.

Edinburgh, UK, May 2006 Association of Surgeons of Great Britain and Ireland, ASGBI 2006 Annual Scientific Meeting,

122. Duplex Ultrasound Arterial Mapping (Duam) as Sole Pre-Operative Evaluation Tool for Endovascular Revacularisation (EVR) in Critical Lower Limb Ischaemia (CLI). A Prospective Study of Duam, Conventional Angiography (CA) and Magnetic Resonance Angiography (MRA)
123. Does single Suprarenal artery clamping alter outcome in Juxtarenal aortic aneurysm repair? A parallel group observational study of the technical and clinical outcome of infrarenal aortic aneurysm repair and suprarenal aortic aneurysm repair.
124. Critical Bleeding in vascular surgery. Expanding the indication of recombinant activated factor VII (rFVIIa).

Las Vegas, Nevada, March 2006, Society for Clinical Vascular Surgery, 34th Annual Symposium on Vascular Surgery,

125. A comparison of open (OR) and endovascular abdominal aortic aneurysm repair (EVAR) with best medical treatment (BMT). Has the availability of EVAR expanded our indications for intervention, and improved survival?
126. A Prospective Observational Study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in High-Risk Patients. Short term results.

Limerick, Ireland, March 2006, Sylvestor O’Halloran Surgical Meeting

127. Non-operative active management of critical limb ischemia (CLI): Initial experience using a sequential compression biomechanical device for limb salvage.
128. Meta-analysis of randomised controlled clinical trials in the management of lower limb venous ulcerations.

XXXXth Sir Peter Freyer Memorial Lecture and Surgical Symposium, Galway, 2005

129. Abdominal Aortic Aneurysm (AAA) repair in Octagenarians versus Younger patients in a tertiary referral centre. 5-year survival arte of non-operative AAA.
130. Open AAA repair using Continuous Auto-Transfusion System (CATS): A Seven-year experience.
131. Homocysteine levels, cardiovascular risk factors and complication rates in vascular surgery and endovascular surgery: is there a correlation?
132. Materialise’s Interactive Medical Imaging Control System (MIMICS) and Finite Element Analysis (FEA) in predicting Abdominal Aortic Aneurysm (AAA) rupture – A prospective study in a tertiary referral centre.
133. A Double-Blinded Randomized Trial of Thin versus Ultra-thin Dacron Patching during Carotid Endarterectomy (CEA): Mid-term Results.
134. How to Pioneer a Vascular Biobank. An Initial Experience.

Glasgow, 2005. Association of Surgeons of Great Britain and Ireland, Annual Meeting,

135. Short-term results of a prospective study of Carotid artery Stenting (CAST) under neuro-protection and Carotid Endarterectomy (CEA) in high risk patients.

Galway, 2005. Irish Angiology Society conference.

136. A Novel Model for Adventitial Gene Delivery to Balloon-Injured Rabbit Carotid Arteries.
137. A comparison of open (OR) and endovascular abdominal aortic aneurysm repair (EVAR) with best medical treatment (BMT). Has the availability of EVAR expanded our indications for intervention, and improved survival?

Limerick, Ireland, March 2005, Sylvestor O’Halloran Surgical Meeting

138. Initial short term experience in non-operative management of critical limb ischaemia (CLI) using a biomedical device.
139. Implementation of the continuous auto-transfusion system (CATS) in open AAA repair: a seven-year experience.

Galway, 2003 XXXVIIIth Sir Peter Freyer Memorial Lecture and Surgical Symposium,

140. Does infection play a role in the pathogenesis of abdominal aortic aneurysm in the west of Ireland? Histopathology, culture and sensitivity results of 24 abdominal aortic aneurysm sacs and their clinical outcome.
141. Redefining the indications of carotid endarterectomy in patients with symptomatic carotid artery stenosis. One-year results of a carotid endarterectomy programme.
142. Outcome of abdominal aortic aneurysm repair in the octogenarian in a tertiary referral centre: does age matter?

Limerick, Ireland, March 2003, Sylvestor O’Halloran Surgical Meeting

143. Lack of association of interleukin-1beta and tumour necrosis factor-alpha polymorphisms with venous ulceration.
144. Comparative study of the use of synthetic graft in aortic and femoral-popliteal segment: does InterGard^TM silver-impregnated Darcon and carbon Distaflo^TM graft offer a better outcome?